RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases
Data up to Jan 2025
Total Citations Per Year
Abstract
References (32)
Classification of Surgical Complications
2004 • 26,400 citations
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 • 3,698 citations
Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer
1999 • 3,538 citations
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
2010 • 2,043 citations
Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients
1996 • 1,658 citations
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
2009 • 1,286 citations
High-throughput oncogene mutation profiling in human cancer
2007 • 995 citations
Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer
2008 • 977 citations
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
2011 • 708 citations
Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases
2008 • 581 citations
Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases
2009 • 477 citations
Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples
2009 • 435 citations
High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome
2011 • 373 citations
KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
2011 • 279 citations
Comparative Genomic Analysis of Primary Versus Metastatic Colorectal Carcinomas
2012 • 264 citations
High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice
2008 • 226 citations
Optimal Morphologic Response to Preoperative Chemotherapy: An Alternate Outcome End Point Before Resection of Hepatic Colorectal Metastases
2012 • 202 citations
KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer
2011 • 199 citations
Margin Status Remains an Important Determinant of Survival After Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy
2013 • 190 citations
KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver Metastases
2009 • 162 citations
KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis
2009 • 151 citations
K-Ras Mutations and Treatment Outcome in Colorectal Cancer Patients Receiving Exclusive Fluoropyrimidine Therapy
2008 • 150 citations
Two-Surgeon Technique for Hepatic Parenchymal Transection of the Noncirrhotic Liver Using Saline-Linked Cautery and Ultrasonic Dissection
2005 • 145 citations
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
2012 • 134 citations
KRAS and BRAF Mutational Status in Primary Colorectal Tumors and Related Metastatic Sites: Biological and Clinical Implications
2010 • 114 citations
Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver
1991 • 100 citations
Adjuvant Chemotherapy With FOLFOX for Primary Colorectal Cancer Is Associated With Increased Somatic Gene Mutations and Inferior Survival in Patients Undergoing Hepatectomy for Metachronous Liver Metastases
2012 • 71 citations
Tumor Thickness at the Tumor-normal Interface: A Novel Pathologic Indicator of Chemotherapy Response in Hepatic Colorectal Metastases
2010 • 70 citations
KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab
2012 • 68 citations
Predictive and Prognostic Markers in Colorectal Cancer
2011 • 60 citations
Natural History of Patients with Subcentimeter Pulmonary Nodules Undergoing Hepatic Resection for Metastatic Colorectal Cancer
2009 • 57 citations
KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer
2012 • 31 citations
Cited By (0)
No citing papers found in database